Innopiphany looks at drug pricing policies
LOS ANGELES — Going into the 2020 election, drug pricing remains a key topic of discussion, and has been so for a long time as almost half of all Americans take at least one prescription medication daily. While lawmakers continue to promise reform, nearly all regulatory progress stalls before it can take effect. The key
